June 20 (Reuters) - A bid by GSK (GSK.L), opens new tab and other drugmakers to stop more than 70,000 lawsuits in Delaware over discontinued heartburn drug Zantac has received the backing of leading U ...
On August 10, 2022, Deutsche Bank reported that it seemed “very possible” that GSK “will incur the risk of some degree of shared liability, with the only real questions being what the magnitude of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback